ASH 2019 (Orlando): Researchers to Present Posters on Efficacy of ONC201 in AML and Myelofibrosis
A) ONC201 and ONC212 efficacy in AML Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia. Michael Andreeff, MD, PhD and Jo Ishizawa, MD, PhD. Department of Leukemia, The University of Texas MD Anderson Cancer Center Number: 2562, Link: https://ash.confex.com/ash/2019/webprogram/Paper127101.html Sunday, December 8, 2019, 6:00 PM-8:00 PM Hall B, Level 2 (Orange County Convention Center)
Business Development